Transferring Methadone-Stabilized Pregnant Patients to Buprenorphine Using an Immediate Release Morphine Transition: An Open-Label Exploratory Study

REFERENCES

• Jones HE, Johnson RE, Jasinski DR. , et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79:1–10. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40, DHHS Publication Number (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004.
   Google Scholar
• Walsh SL, June HL, Schuh KJ, , et al. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology. 1995;119:268–276. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Breen CL, Harris SJ, Lintzeris N, , et al. Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depend. 2003;71:49–55. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Strain EC, Preston KL, Liebson IA, Bigelow GE. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. J Pharmacol Exp Ther. 1995;272:628–638. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bouchez J, Beauverie P, Touzeau D. Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients: preliminary results. Eur Addict Res. 1998;4(Suppl1):8–12. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Clark N, Muhleisen P, , et al. Clinical guidelines: buprenorphine treatment of heroin dependence. Public Health Division, Commonwealth of Australia. Available at: http://hna.ffh.vic.gov.au/phd/buprenorphine/. Accessed March 2001.
   Google Scholar
• Breen CL, Harris SJ, Lintzeris N, , et al. Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depend. 2003;71:49–55. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Banys P, Clark HW, Tusel DJ, , et al. An open trial of low dose buprenorphine in treating methadone withdrawal. J Subst Abuse Treat. 1994;11:9–15. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fischer G, Etzersdorfer P, Eder H, , et al. Buprenorphine maintenance in pregnant opiate addicts. Eur Addict Res. 1998;4(Suppl 1):32–36. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fischer G, Johnson RE, Eder H, , et al. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction. 2000;95:239–244. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Levin FR, Fischman MW, Connerney I, , et al. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine. Am J Addict. 1997;6:105–116. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Greenwald MK, Johanson CE, Schuster CR. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance. Drug Alcohol Depend. 1999;56:191–203. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(2 Suppl):S13–27. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eissenberg T, Greenwald MK, Johnson RE, , et al. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans. J Pharmacol Exp Ther. 1996;276:449–459. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Martin WR, Jasinski DR, Haertzen CA, , et al. Methadone—a reevaluation. Arch Gen Psychiatry. 1973;28:286–295. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hadlock FP, Harris RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology. 1991;181:129–133. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kumm S, http://classes.kumc.edu/son/nurs420/unit11/FHT.htm. Accessed: July 2003.
   Google Scholar
• Pritchard J, MacDonald P, Gant N. Williams Obstetrics. 17th ed. Norwalk, Conn.: Appleton-Century-Crofts; 1985.
   Google Scholar
• Johnson RE, Cone EJ, Henningfield JE, , et al. Use of buprenorphine in the treatment of opiate addiction: I. physiologic and behavioral effects during a rapid dose induction. Clin Pharmacol Ther. 1989;46:335–343. [CSA]
   Web of Science ®Google Scholar
• Kuhlman Jr. JL, Levin B, Johnson RE, , et al. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction. 1998;93:549–559. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar